Precision Oncology Market is expected to increase at a compound annual growth rate (CAGR) of 13.8% from 2025 to 2035
The market for precision oncology market was estimated to be worth USD 103.7
billion in 2024, and a compound annual growth rate of 13.8% is anticipated over
the course of the projection period. The main factors driving the market are
the growing impact of technology, the growing need to reduce the adverse
effects of cancer treatments, and the avoidance of particular drug resistance.
The market is expanding due to growing demand for early detection of breast
cancer, the expansion of the biotechnology industry, and rising healthcare
costs worldwide.
Innovation and
the creation of new treatments are accelerated by rising governmental and
private sector investment in research and development. The market is expanding
due to favorable government financing and initiatives.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/precision-oncology-market
Growth
Drivers
The market is
expanding due to a number of factors, including favorable government programs
and funding, growing awareness of precision medicine, and technological
advancements. More accurate detection of genetic alterations and biomarkers is
made possible by advances in cancer genomics and the development of
technologies such as next-generation sequencing. Transition to personalized
medicine, which improves the effectiveness of cancer therapy and minimizes side
effects by customizing medicines to each patient's unique genetic profile.
The market is
greatly boosted by favorable regulatory regulations and expedited approvals for
novel treatments and diagnostics. The market is expanding due in large part to
the rising incidence of uterine fibrosis, breast cancer, and cancer worldwide.
Another important aspect of the precision oncology industry is the growing need
for customized medications.
Segmentation
Type
· Breast
Cancer
· Prostate
Cancer
· Stomach
Cancer
· Liver
Cancer
· Mouth
Cancer
· Skin
Cancer
· Others
By
Products Type
· Therapeutics
· Diagnostics
By
End-User
· Hospitals
· Diagnostic
Centers
· Research
and Academic Institutes
· Others
Regional
Outlook
· Asia
Pacific
· North
America
· Latin
America
· Europe
· Middle
East and Africa
Key
Players
· Thermo
Fisher Scientific Inc.
· Novartis
AG
· Pfizer
Inc.
· Agendria
Inc.
· Rain
Therapeutics Inc.
· Strata
Oncology, Inc.
· F.Hoffman
La Roche Ltd.
· Qiagen
N.V.
· Invitae
Corporation
· Erasca
Inc.
· Other
Players
For More Information about this Report @
https://www.xresearch.biz/shop/precision-oncology-market
About Us: -
xResearch is a market research and consulting
organization that uses unique data, expert analysis, and new technologies to
create trusted intelligence on industries. Our research is focused on
delivering an informed and impartial view on essential market data of industry,
and it is primarily driven by an in-depth study covering the following
parameters: Market Sizing and Forecasting, Market Segmentation, Competitive
Analysis, Strategic Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment